2BED
Structure of FPT bound to inhibitor SCH207736
Summary for 2BED
Entry DOI | 10.2210/pdb2bed/pdb |
Descriptor | Protein farnesyltransferase/geranylgeranyltransferase type I alpha subunit, Protein farnesyltransferase beta subunit, ZINC ION, ... (6 entities in total) |
Functional Keywords | fpt, ptase, farnesyl, drug design, transferase |
Biological source | Rattus norvegicus (Norway rat) More |
Total number of polymer chains | 2 |
Total formula weight | 83491.41 |
Authors | Strickland, C. (deposition date: 2005-10-24, release date: 2006-08-08, Last modification date: 2024-02-14) |
Primary citation | Njoroge, F.G.,Vibulbhan, B.,Pinto, P.,Strickland, C.,Bishop, W.R.,Nomeir, A.,Girijavallabhan, V. Enhanced FTase activity achieved via piperazine interaction with catalytic zinc. Bioorg.Med.Chem.Lett., 16:984-988, 2006 Cited by PubMed Abstract: Benzocycloheptapyridine tricyclic compounds with piperazine or substituted piperidine moieties extending either from the 5- or 6-position of the tricyclic bridgehead exhibited enhanced FTase activity: this resulted from favorable binding of the ligand nitrogen with the catalytic zinc found in the FTase. A single isomer at C-11 with piperazine adduct extending from the 6-position, compound 24, exhibited excellent FTase activity with IC50 = 0.007 microM, soft agar IC50 = 72 nM, and Rat AUC(PO, 10 mpk) = 4.0 microM x h. X-ray of (-)-[8-chloro-6-(1-piperazinyl)-1H-benzo[5,6]]cyclohepta[1,2-b]pyridine-11-yl]-1-(methylsulfonyl)piperidine 24 bound to Ftase revealed favorable interaction between piperazine nitrogen and catalytic zinc atom. PubMed: 16298128DOI: 10.1016/j.bmcl.2005.10.090 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.7 Å) |
Structure validation
Download full validation report
